In this study, we systematically screened all available cDNA microarray datasets between responders and non-responders to anti-TNFα therapy, in patients with IBD, PsO and RA, and conducted a random effects meta-analysis, aiming to identify unique and shared genes and pathways that could be potentially related to the phenotypically complex response to therapy. The gene discussed is TNF; the disease is inflammatory bowel disease.